TD Waterhouse Canada’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-282
Closed -$3.88K 2422
2026
Q1
$3.88K Sell
282
-2,136
-88% -$29.9K ﹤0.01% 1954
2025
Q4
$34.7K Sell
2,418
-75,251
-97% -$1.13M ﹤0.01% 1275
2025
Q3
$1.22M Sell
77,669
-24,673
-24% -$406K 0.01% 532
2025
Q2
$1.84M Buy
102,342
+65,048
+174% +$1.27M 0.01% 439
2025
Q1
$771K Buy
37,294
+17,952
+93% +$340K 0.01% 568
2024
Q4
$358K Buy
+19,342
New +$372K ﹤0.01% 682
2024
Q1
Sell
-855
Closed -$15.2K 1793
2023
Q4
$15.2K Buy
855
+799
+1,427% +$15.9K ﹤0.01% 1173
2023
Q3
$1.52K Buy
56
+4
+8% +$76 ﹤0.01% 1524
2023
Q2
$1.28K Buy
+52
New +$1.05K ﹤0.01% 1586
2023
Q1
Sell
-35,900
Closed -$770K 1746
2022
Q4
$770K Buy
+35,900
New +$744K 0.01% 449
2022
Q3
Sell
-1,495
Closed -$41.9K 1714
2022
Q2
$41.9K Buy
+1,495
New +$30.2K ﹤0.01% 956

Other funds holding BTAL

TD Waterhouse Canada's BTAL Position: Q2 2026 in Review

TD Waterhouse Canada sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 282 shares — an estimated $3.88K sold.

TD Waterhouse Canada first reported a position in BTAL in Q2 2022 and held it in 11 quarters. The position peaked at $1.84M in Q2 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • TD Waterhouse Canada reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 282 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $3.88K.
  • TD Waterhouse Canada first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2022 and held it in 11 quarters.
  • TD Waterhouse Canada's AGF US Market Neutral Anti-Beta Fund position peaked at $1.84M in Q2 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.